Reaction Details Report a problem with these data
Target
D(3) dopamine receptor
Ligand
BDBM476842
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
0.092±n/a nM
Citation
 Tobinaga, H; Masuda, K; Inagaki, M; Yonehara, M; Masuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent  US10870660 Publication Date 12/22/2020 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM476842
Synonyms:
US10870660, Compound III-624 | US11345716, Compound III-624
Type:
Small organic molecule
Emp. Form.:
C27H33F2N5O2S
Mol. Mass.:
529.645
SMILES:
Cn1cc2c(cccc2n1)C(=O)NC1CC2(CC(CCN3CCc4sc(OCC(C)(F)F)nc4C3)C2)C1 |(12.98,-1.91,;12.21,-.58,;10.67,-.42,;10.35,1.09,;9.02,1.86,;9.02,3.4,;10.35,4.17,;11.69,3.4,;11.69,1.86,;12.83,.83,;7.69,1.09,;7.69,-.45,;6.35,1.86,;5.02,1.09,;4.62,-.4,;3.13,,;2.73,-1.49,;1.25,-1.09,;-.09,-1.86,;-1.42,-1.09,;-2.75,-1.86,;-2.75,-3.4,;-4.09,-4.17,;-5.42,-3.4,;-6.89,-3.87,;-7.79,-2.63,;-9.33,-2.63,;-10.1,-1.3,;-11.64,-1.3,;-12.41,.04,;-11.64,-2.84,;-12.98,-2.07,;-6.89,-1.38,;-5.42,-1.86,;-4.09,-1.09,;1.65,.4,;3.53,1.49,)|
Structure:
Search PDB for entries with ligand similarity: